Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.
Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check24 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this aspect.SummaryDifference0.2%
- Check53 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has updated the contact details section for the study, now specifying that it provides information for those interested in joining the study, along with a reference to the Contacts and Locations section in the How to Read a Study Record.SummaryDifference2%
- Check74 days agoChange DetectedThe website has added a 'Show less' feature, while several detailed data fields and options related to participant groups, interventions, and study details have been removed.SummaryDifference3%
Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.